awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46517959-4EF8B1C6-C545-44F0-9202-E53F829A209E
Q46517959-4EF8B1C6-C545-44F0-9202-E53F829A209E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46517959-4EF8B1C6-C545-44F0-9202-E53F829A209E
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
P2860
Q46517959-4EF8B1C6-C545-44F0-9202-E53F829A209E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46517959-4EF8B1C6-C545-44F0-9202-E53F829A209E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6930d92ff54a0b7e1e9e9c11eec11b8b9d2e0998
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.